Sign in
CompletedPhase 3

Clomiphene Citrate in Infertile Men With Idiopathic Oligoasthenozoospermia

Key facts

Who runs it
Shakeela Ishrat
Where
Bangladesh1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
50 people enrolled
Started
1 Jul 2022
Ended
31 Dec 2023
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Clomiphene Citrate
  • Placebo
Record updated
23 August 2024

Who can take part

Age
25 years to 45 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Infertile men
  • Idiopathic oligoasthenozoospermia (serum FSH and serum LH range was 2-7 IU/mL and serum testosterone level was >300 ng/dl)

Who cannot take part

  • Antioxidant supplements in previous 3 months
  • Smoking, drug, alcohol or substance abuse
  • History of genital diseases \& genital surgery
  • Medical and endocrine disorders like uncontrolled diabetes mellitus, severe kidney disease and liver insufficiency
  • History of chemotherapy or radiotherapy
  • Azoospermia
  • Body mass index <18 kg/m2 and >30 kg/m2
  • Any abnormality on genital examination and scrotal sonogram
  • Psycho-sexual abnormalities
  • Presence of any gross female factor abnormality

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if drug clomiphene citrate improves sperm parameters in infertile men with idiopathic oligoasthenozoospermia. It will also learn about the safety of clomiphene citrate. The main questions it aims to answer are:

Read full original descriptionShow less

* Does drug clomiphene citrate change sperm count and motility in infertile men with idiopathic oligoasthenozoospermia? * What medical problems do participants have when taking drug clomiphene citrate? Researchers will compare drug clomiphene citrate to a placebo (a look-alike substance that contains no drug) to see if drug clomiphene citrate works to treat idiopathic oligoasthenozoospermia.

The 2 groups in the trial

  • ClomipheneTreatment being tested

    Participants will receive Tab Clomiphene citrate 50 mg orally once daily or 12 weeks

    Treatment: Clomiphene Citrate

  • PlaceboPlacebo, for comparison

    Participants will receive Clomiphene citrate placebo tablet matching Clomiphene citrate orally once daily for 12 weeks

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Clomiphene Citrate on Sperm Parameters in Infertile Men With Idiopathic Oligoasthenozoospermia
Record updated
23 August 2024